Only a decade ago, AI transactional work was limited. AI was in the background, relevant mainly for the tech industry but not a priority for most industries, and generative AI wasn’t on the radar for most people. It’s fair to say things have changed. In this video, Adrian Perry discusses key considerations for #AI transactions. You can watch the full series here: https://okt.to/gS9idQ
关于我们
From our offices in Beijing, Boston, Brussels, Dubai, Frankfurt, Johannesburg, London, Los Angeles, New York, Palo Alto, San Francisco, Seoul, Shanghai, and Washington, we practice as one firm, holding closely to core values that start with a deep commitment to our clients and the quality of our work on their behalf, and that include an emphasis on teamwork among our lawyers and other professionals and a belief in the obligation of lawyers to make legal services available to all who need them. Our lawyers are recognized nationally and internationally for their legal skills and the depth of their expertise. Many have served in senior government positions. Virtually all of them provide public service through pro bono representation. We are cultivating a diverse, equitable, and inclusive firm that harnesses the abilities of every colleague and the power of diverse perspectives to help clients navigate their most complex business challenges. And because every client is a client of the firm, not of any specific lawyer, every client has the ability to call on any of our lawyers as needed.
- 网站
-
https://www.cov.com
Covington & Burling LLP的外部链接
- 所属行业
- 律师事务所
- 规模
- 1,001-5,000 人
- 总部
- Washington，D.C.
- 类型
- 合营企业
- 创立
- 1919
地点
Covington & Burling LLP员工
动态
-
By 2030, the U.S. “algorithm economy” is projected to grow to more than 9 percent of electricity demand, or “load.” To sustain American leadership in artificial intelligence will require unprecedented investment in new generation power to serve load. Mark Perlis and Eva Dorrough discuss how the Trump administration might address the challenge: https://okt.to/M1gw69
-
-
President Trump issued an Executive Order titled “Ensuring Lawful Governance and Implementing the President’s ‘Department of Government Efficiency’ Deregulatory Initiative.” This alert discusses the opportunities and challenges for stakeholders: https://okt.to/AYkfRS
-
-
As China’s 2025 regulatory plans for drugs and medical devices take shape, a recently released document provides a helpful blueprint for further reform from 2027 to 2035. Muyun Hu, John Balzano, and Julia Post provide an overview: https://okt.to/Qlvabs
-
-
In the latest in a series of executive actions that aim to reshape much of government, President Trump signed an executive order on February 18 expanding the President’s authority over so-called independent agencies within the executive branch. The impact of this executive order will be felt across the federal government, and it remains to be seen how exactly the White House will seek to exercise its asserted authority. In particular, the order could have important effects on future rulemakings and advisory opinions from the Federal Election Commission. This alert explains: https://okt.to/Oxq9tv
-
-
State lawmakers are considering a diverse array of AI legislation, with hundreds of bills introduced in 2025. Many of these AI legislative proposals fall into several key categories, which Jennifer Johnson, Jayne Ponder, August Gweon, and Analese B. discuss in this blog post: https://okt.to/If5y3K
-
-
Join Covington’s David Berman, David Lorello, Michael Nonaka, and Ian Redfearn on March 4, for our webinar on the latest anti-money laundering and sanctions developments in the U.S. and UK. Find out more and register here: https://okt.to/Ct3cAw
-
-
The Trump Administration and Republican-controlled Congress appear committed to a significant curtailment of the CFPB's rulemaking activity—if not halting it altogether—and to nullifying many of the rules previously promulgated. This alert discusses the potential pathways: https://okt.to/4yTMoN
-
-
Join us for a panel discussion in London on March 5 where industry leaders will discuss strategies and challenges of successful partnering between biotech and pharma. Find out more and register here: https://okt.to/6wCRUo
-
The Trump Administration issued an Executive Order asserting Presidential authority over independent agencies, including the Federal Trade Commission, Federal Communications Commission, and Securities and Exchange Commission. This blog looks at the potential implications: https://okt.to/cT48hZ
-